David Sidransky

David Sidransky

Vermogen: 5 M $ op 30-06-2026

66 jaar
Health Technology
Health Services
Consumer Services

Profiel

David Sidransky founded Israel Biotech Fund in 2014, where he is working as General partner from 2014 and Champions Oncology, Inc. in 1985, where he is working as Independent Director from 2025.
Dr. Sidransky also currently works at Biosight Therapeutics, Inc., as Chairman from 2013, Advaxis Immunotherapies, as Chairman, Ayala Pharmaceuticals, Inc., as Chairman from 2017, and various other companies.
Dr. Sidransky also formerly worked at Tamir Biotechnology, Inc., as Chairman from 2007 to 2020, ImClone LLC, as Vice Chairman from 2004 to 2008, Old Ayala, Inc., as Chairman from 2017 to 2023, and various other companies.
Dr. Sidransky received his undergraduate degree in 1981 from Brandeis University and doctorate degree from Baylor College of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
05-11-2025 767.043 ( 5,52% ) 5 M $ 30-06-2026
20-04-2026 18.491 ( 0% ) 78 283 $ 30-06-2026
25-03-2026 11.083 ( 0,17% ) 6 162 $ 30-06-2026

Actieve functies van David Sidransky

BedrijvenFunctieBegin
CHAMPIONS ONCOLOGY, INC. Oprichter 04-06-1985
GALMED PHARMACEUTICALS LTD. Directeur/Bestuurslid 01-06-2014
IMMUNE PHARMACEUTICALS, INC. Directeur/Bestuurslid 26-08-2013
ROSETTA GENOMICS LTD. Directeur/Bestuurslid 22-12-2009
ASCENTAGE PHARMA GROUP INTERNATIONAL Directeur/Bestuurslid 31-03-2021
AYALA PHARMACEUTICALS, INC. Voorzitter 01-11-2017
Corporate Officer/Principal 01-01-1994
Corporate Officer/Principal 01-07-1998
Directeur/Bestuurslid -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Eerdere bekende functies van David Sidransky

BedrijvenFunctieEinde
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░ ░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van David Sidransky in detail bekijken

Opleiding van David Sidransky

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

58

Eerstegraads connecties

35

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Services

Health Technology

Clinical Cancer Research

Commercial Services

Health Services

Health Services

Government

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

The American Association of Cancer Research

Health Services

Health Technology

  1. Beurs
  2. Insiders
  3. David Sidransky